original ) (raw )Evaluation of 3-deaza-adenosine analogues as ligands for adenosine kinase and inhibitors of Mycobacterium tuberculosis growth
William G Parker
Journal of Antimicrobial Chemotherapy, 2006
View PDFchevron_right
Structural Basis for Inhibition of Mycobacterial and Human Adenosine Kinase by 7-Substituted 7-(Het)aryl-7-deazaadenine Ribonucleosides
Petr Konecny
Journal of Medicinal Chemistry, 2014
View PDFchevron_right
Inhibition of Siderophore Biosynthesis in Mycobacterium tuberculosis with Nucleoside Bisubstrate Analogues: Structure−Activity Relationships of the Nucleobase Domain of 5′-O-[N-(Salicyl)sulfamoyl]adenosine
Jagadeshwar Vannada
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
Leads for antitubercular compounds from kinase inhibitor library screens
Laszlo F Orfi , Csaba Szántai-kis
2010
View PDFchevron_right
3′-Bromo Analogues of Pyrimidine Nucleosides as a New Class of Potent Inhibitors ofMycobacterium tuberculosis
Babita Agrawal
Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Design, synthesis, and biological evaluation of beta-ketosulfonamide adenylation inhibitors as potential antitubercular agents
Jagadeshwar Vannada
Organic letters, 2006
View PDFchevron_right
New Antitubercular Drugs Designed by Molecular Modification
Luiz Antonio
Understanding Tuberculosis - New Approaches to Fighting Against Drug Resistance, 2012
View PDFchevron_right
Design, synthesis and inhibitory activity against Mycobacterium tuberculosis thymidine monophosphate kinase of acyclic nucleoside analogues with a distal imidazoquinolinone
Hélène Munier-lehmann
European Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Inhibition of Siderophore Biosynthesis by 2Triazole Substituted Analogues of 5′- O -[ N -(Salicyl)sulfamoyl]adenosine: Antibacterial Nucleosides Effective against Mycobacterium tuberculosis
joao neres
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
Discovery and validation of new antitubercular compounds as potential drug leads and probes
Barbara Laughon
Tuberculosis, 2009
View PDFchevron_right
Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains
Christophe Brigaudeau
Journal of Medicinal Chemistry, 2013
View PDFchevron_right
Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors
Perumal Yogeeswari
European Journal of Medicinal Chemistry, 2015
View PDFchevron_right
ADMET & Molecular Docking Studies of Novel 2, 4-dioxo-4-phenyl butanoic acid analogs as Mycobacterium Tuberculosis Inhibitors
manal elhag
2013
View PDFchevron_right
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by Novel Dideoxy Nucleosides
Babita Agrawal
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in Mycobacterium tuberculosis
Dr. Srinivasan Ramachandran
2020
View PDFchevron_right
6-Alkyl-, 6-aryl- or 6-hetaryl-7-deazapurine ribonucleosides as inhibitors of human or MTB adenosine kinase and potential antimycobacterial agents
Petr Konecny
MedChemComm, 2013
View PDFchevron_right
Design, synthesis, and characterization of (1-(4-aryl)-1H -1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis
Mahesh Attimarad
Drug Design, Development and Therapy, 2016
View PDFchevron_right
Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis
Rosanna Filosa
Bioorganic & Medicinal Chemistry, 2007
View PDFchevron_right
Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis
Raj Khan
Bioorganic & Medicinal Chemistry, 2015
View PDFchevron_right
3‘-C-Branched-Chain-Substituted Nucleosides and Nucleotides as Potent Inhibitors of Mycobacterium tuberculosis Thymidine Monophosphate Kinase
Denis Keukeleire
Journal of Medicinal Chemistry, 2003
View PDFchevron_right
Rational Design of New Antituberculosis Agents: Receptor-Independent Four-Dimensional Quantitative Structure−Activity Relationship Analysis of a Set of Isoniazid Derivatives
Kerly Pasqualoto
Journal of Medicinal Chemistry, 2004
View PDFchevron_right
Mycobacterium tuberculosis Thymidine Monophosphate Kinase Inhibitors: Biological Evaluation and Conformational Analysis of 2′- and 3′-Modified Thymidine Analogues
Hélène Munier-lehmann
European Journal of Organic Chemistry, 2003
View PDFchevron_right
Design of Thymidine Analogues Targeting Thymidilate Kinase of Mycobacterium tuberculosis
S. Miertus , Vladimir Frecer
Tuberculosis Research and Treatment, 2013
View PDFchevron_right
Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating Mycobacterium tuberculosis
Dhiman Sarkar
Journal of Biomolecular Structure and Dynamics, 2020
View PDFchevron_right
Recent Advances in New Structural Classes of Anti-Tuberculosis Agents
rahul jain
Current Medicinal Chemistry, 2005
View PDFchevron_right
Comparative protein modeling of methionine S-adenosyltransferase (MAT) enzyme from Mycobacterium tuberculosis: a potential target for antituberculosis drug discovery
Santosh Khedkar
Journal of Molecular Graphics & Modelling, 2005
View PDFchevron_right
Mycobacterium tuberculosis sterol 14α -demethylase inhibitor sulfonamides : Identified by high-throughput screening
Sayantan Pradhan
View PDFchevron_right
Sulfonamide derivatives as Mycobacterium tuberculosis inhibitors: in silico approach
Chittaranjan Sinha
In Silico Pharmacology, 2018
View PDFchevron_right
Computer-assisted combinatorial design of bicyclic thymidine analogs as inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase
S. Miertus , Vladimir Frecer
Journal of Computer-Aided Molecular Design, 2011
View PDFchevron_right
Development of Novel Bacteriostatic Agents against Mycobacterium tuberculosis Using In silico Techniques
Anupama Pandrangi
Pharmaceutica Analytica Acta, 2015
View PDFchevron_right
Chemoinformatic Identification of Novel Inhibitors against Mycobacterium tuberculosis L-aspartate α-decarboxylase
Tony Vandongen
PLoS ONE, 2012
View PDFchevron_right
5-Arylaminouracil Derivatives: New Inhibitors ofMycobacterium tuberculosis
Elena Matyugina
Chemical Biology & Drug Design, 2015
View PDFchevron_right
Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents
Suvarna Kini
Drug Design, Development and Therapy, 2015
View PDFchevron_right
Molecular Modeling of Nucleotide Derivatives of 2.5-DIHYDROFURAN-2,5-DIOL for Evaluation of Potential Antitubercular Activity
Alex monteiro Monteiro
Proceedings of MOL2NET 2018, International Conference on Multidisciplinary Sciences, 4th edition, 2018
View PDFchevron_right